Convidado
ZAHRA DANTES
DVM, DVSC, PhD; Chief Scientific Officer (CSO) Invitrocue
Atividades
20/11/2020
Plenária
13:00 às 13:45 - The use of Patient Derived Organoids (PDO) for drug screening in Precision Oncology
13:12 às 13:27 - Translational Applications of Patient-Derived Organoids: 3D In Vitro Model for Personalised Drug Screening
Speaker
20/11/2020
Plenária
13:00 às 13:45 - The use of Patient Derived Organoids (PDO) for drug screening in Precision Oncology
13:37 às 13:45 - Debate
Discussant
